NCT06268327 2024-02-20Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard ChemotherapyAssiut UniversityPhase 2/3 Not yet recruiting30 enrolled
NCT04890522 2021-05-18An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPCSun Yat-sen UniversityPhase 2/3 Not yet recruiting622 enrolled